Additionally, serum FGF-21 levels in fatty liver or diabetic patients were higher than those in the participants in the NC group, with a negative correlation with serum HDL and a positive correlation with BMI and serum TG (Li et al., 2018). Here, FGF21 is linked to digestive system neoplasm.